Top Markets
Coin of the day
Human Metabolome Technologies, Inc. Human Metabolome Technologies, Inc.

Human Metabolome Technologies, Inc.

6090
株式のランク #29371
Human Metabolome Technologies, Inc. is a biotechnology company based in... Human Metabolome Technologies, Inc. is a biotechnology company based in Tsuruoka, Japan, established in 2003. It focuses on developing and providing metabolomics technologies and solutions for a range of applications, including drug discovery, disease diagnosis, and food production primarily within Japan. The company offers a comprehensive suite of metabolome analysis services, encompassing global profiling, targeted assays, flux analysis, and lipidomics. Additionally, it develops biomarkers, such as Phosphorylethanolamine, which is measured in blood plasma as a marker for major depressive disorder. HMT's solutions address diverse areas like cancer metabolism, infectious diseases, basic and clinical research, food and nutrition, and microbiome studies. The company also fosters collaborations, notably with the Institute for Advanced Biosciences and Keio University, to further advance metabolome analysis technology.
株価
$3.86
時価総額
$21.49M
変化(1日)
-0.17%
変化(1年)
-25.27%
JP
取引 Human Metabolome Technologies, Inc. (6090)

カテゴリー

Human Metabolome Technologies, Inc.(6090)の発行済株式数
August 2026 時点の発行済株式数 0
Human Metabolome Technologies, Inc. の最新の財務報告および株価によると、現在の発行済株式数は 0 です。August 2026 の終わりには、同社は 0 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Human Metabolome Technologies, Inc.(6090)の発行済株式数の履歴(2026 ~ 2026)
各年末時点の発行済株式数
発行済株式数 変化
提供された日付のデータは十分ではありません。
類似企業や競合他社の発行済株式数
企業 発行済株式数
253.90M -
US
62.19M -
NL
396.00M -
US
483.58M -
AU
- -
CH